| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc. (NTLA) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. NTLA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $14.47M | - | |
| Dir | 207.5K | $2.96M | - | |
| Dir | 134.7K | $1.92M | - | |
| VP | 121.2K | $1.73M | - | |
| VP | 101.5K | $1.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2020 | Leonard John M83 | President And CEO | Sale+OE | 35,000 | $38.57 | $1,350,000.00 | -3.6% | |
| Nov 25, 2020 | Leonard John M83 | President And CEO | Sale+OE | 50,000 | $36.00 | $1,800,000.00 | -9.7% | |
| Nov 18, 2020 | Rivera Jose E | EVP, General Counsel | Sale+OE | 6,653 | $34.36 | $228,568.45 | -3.4% | |
| Nov 16, 2020 | Leonard John M83 | President And CEO | Sale+OE | 20,000 | $34.00 | $680,000.00 | -4.1% | |
| Nov 4, 2020 | Rivera Jose E | EVP, General Counsel | Sale+OE | 3,364 | $28.00 | $94,192.00 | -7.4% | |
| Nov 4, 2020 | Leonard John M83 | President And CEO | Sale+OE | 50,000 | $26.00 | $1,300,000.00 | -9.7% | |
| Oct 15, 2020 | Rivera Jose E | EVP, General Counsel | Sale+OE | 5,615 | $24.20 | $135,883.01 | -6.4% | |
| Oct 7, 2020 | Leonard John M83 | President And CEO | Sale+OE | 5,000 | $21.83 | $109,150.00 | -1.1% | |
| Sep 15, 2020 | Rivera Jose E | EVP, General Counsel | Sale+OE | 5,615 | $21.04 | $118,139.60 | -13.4% | |
| Sep 1, 2020 | Leonard John M.83 | President And CEO | Sale+OE | 5,000 | $21.83 | $109,150.00 | -1.1% |